Glenmark Pharma shares soar 8% on FDA clean report, Investec predicts 17% upside
Glenmark Pharma surged 8% to a day’s high of Rs 1,763.90 on BSE after the United States Food & Drug Administration’s (USFDA) Good Manufacturing Practice (GMP) inspection at its Aurangabad …